Search clinical trials for: tenofovir, HBV, HCC, nucleo(t)side analogues, Entecavir

Total 269 results

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B

Chronic Hepatitis b

China
University of Athens

Recruiting

HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV (HERACLIS-BLV)

Hepatitis D

Greece
The Second Affiliated Hospital of Chongqing Medical...
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment (POWER)

Chronic Hepatitis B

China
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer

Hepatocellular Carcinoma | Chronic Hepatitis B

China
National Taiwan University Hospital
PharmaEssentia

Recruiting

Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy

Chronic Hepatitis B Virus Infection

Taiwan
Shanghai Zhimeng Biopharma, Inc.
Tigermed Consulting Co., Ltd

Recruiting

A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB

Hepatitis B, Chronic

China
Sun Yat-sen University

Not yet recruiting

Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) (REHEB)

Resolved Hepatitis B | CD20 Positive B-cell Lymphoma
University of Pennsylvania

Recruiting

Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR)

Hepatitis B | Lung Transplant

United States
Sun Yat-sen University

Recruiting

Antiviral Therapy for Patients With Chronic Hepatitis B Infection

Chronic Hepatitis B Virus Infection

China
Assiut University

Not yet recruiting

Effect of Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood Mononuclear Cells

Hepatitis B, Chronic
PharmaEssentia

Recruiting

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Chronic Hepatitis B Infection | Chronic Hepatitis D Infection

Taiwan
Ascentage Pharma Group Inc.

Recruiting

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Hepatitis B | HBV | Chronic Hep B

China
Ruijin Hospital

Recruiting

Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

B-cell Lymphoma | HBV

China
Aligos Therapeutics

Recruiting

A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Chronic Hepatitis B

Hong Kong, China, United Kingdom, Moldova, Republic of, New Zealand, Australia, Mauritius
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

Chronic Hepatitis b | Cirrhosis Due to Hepatitis B

China
Tanta University

Recruiting

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Helicobacter Pylori Infection

Egypt
Sun Yat-sen University

Recruiting

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Hepatocellular Carcinoma Recurrent

China
National Taiwan University Hospital
AstraZeneca; Ministry of Science and Technology, Taiwan, ROC

Recruiting

Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection

Advanced Hepatocellular Carcinoma

Taiwan
The University of Hong Kong

Recruiting

Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc) (OBI)

Liver Transplant; Complications | Occult Hepatitis B

Hong Kong
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis

Hepatitis B | Compensated Cirrhosis

China
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b

Chronic Hepatitis b

China
Sunshine Lake Pharma Co., Ltd.

Recruiting

Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

Chronic HBV Infection

China
Taichung Veterans General Hospital

Recruiting

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Hepatitis B | Viral Hepatitis

Taiwan
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF (HBV)

Acute-On-Chronic Liver Failure | Hepatitis B

China
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

Liver Failure | Virus Diseases | Hepatitis B

China
Janssen Research & Development, LLC

Active, not recruiting

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (REEF-D)

Hepatitis D, Chronic

France, Taiwan, Italy, Germany, Japan, Spain, Russian Federation, Turkey, United Kingdom, Australia, Sweden, United States, New Zealand, China, Brazil
Janssen Research & Development, LLC

Active, not recruiting

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants (OCTOPUS-1)

Hepatitis B, Chronic

France, Canada, Czechia, Italy, Taiwan, Turkey, Spain, United Kingdom
Ascletis Pharmaceuticals Co., Ltd.

Completed

Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV

Hepatitis B, Chronic

China
SWOG Cancer Research Network
National Cancer Institute (NCI)

Terminated

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

Malignant Solid Neoplasm | Hepatitis B Infection

United States, Guam
Daewoong Pharmaceutical Co. LTD.

Active, not recruiting

The Efficacy and Safety of Switching to Vemliver Tab From Entecavir in Chronic Hepatitis B Patients Who Pretreated With Entecavir

Hepatitis B, Chronic

Korea, Republic of
Janssen Research & Development, LLC

Completed

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection (INSIGHT)

Hepatitis B

France, United States, Belgium, United Kingdom, Poland, New Zealand, Germany, Italy, Canada
Guangxi Medical University

Completed

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Hepatocellular Carcinoma

China
Bristol-Myers Squibb

Completed

A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting

Hepatitis B Virus

Japan
Assembly Biosciences
Arbutus Biopharma Corporation

Terminated

A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection

Chronic Hepatitis B

Australia, Canada, Bulgaria, New Zealand
Suzhou Ribo Life Science Co. Ltd.

Completed

A Single and Repeated Dose Escalation of RBD1016 in Subjects With Chronic Hepatitis B Virus (HBV) Infection

Chronic Hepatitis b

China
Assembly Biosciences

Terminated

A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B

China
Janssen Sciences Ireland UC

Completed

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

Belgium, United Kingdom, France, Italy, Germany, Spain, Poland
Janssen Research & Development, LLC

Terminated

A Single and Multiple Ascending Dose Study of JNJ-64457744

Healthy | Hepatitis B, Chronic

New Zealand
Janssen Research & Development, LLC

Completed

A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection (PENGUIN)

Hepatitis B, Chronic

Taiwan, Poland, Japan, New Zealand
The University of Hong Kong

Active, not recruiting

Stopping Antiviral Treatment in Chronic Hepatitis B

Chronic Hepatitis b

Hong Kong
Assembly Biosciences

Terminated

A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients

Chronic Hepatitis B

United States, Canada, Hong Kong, New Zealand, United Kingdom
Sunshine Lake Pharma Co., Ltd.

Suspended

Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Hepatitis B, Chronic

China
Sunshine Lake Pharma Co., Ltd.

Completed

Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Hepatitis B, Chronic

China
E-DA Hospital

Active, not recruiting

Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis B

Chronic Hepatitis b

Taiwan
Chinese University of Hong Kong

Active, not recruiting

Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir

Chronic Hepatitis B

Hong Kong
First Affiliated Hospital of Zhejiang University

Completed

Synbiotics Interventions for Managing Cirrhosis and Its Complications

Cirrhosis, Liver | Metagonimiasis

China
Dong-Gun Lee

Enrolling by invitation

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

HBV | Hematopoietic Stem Cell Transplantation | Hepatitis B Reactivation | Antiviral Drug

Korea, Republic of
Pacific Health Foundation
Bristol-Myers Squibb

Completed

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders (ADVPR)

Hepatitis B

United States
Enyo Pharma
Parexel; Novotech (Australia) Pty Limited; Synteract, Inc.; Eurofins

Terminated

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Hepatitis B, Chronic

Australia, Hong Kong, Korea, Republic of, Poland
Janssen Pharmaceutica N.V., Belgium

Withdrawn

A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment (SALMONS)

Hepatitis B, Chronic

Germany, France, Italy, Spain, Denmark, Portugal, Greece

3

Subscribe